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SUMMARY
Heart failure is a primary health concern in North and South 
America, with hospitalizations for heart failure as the primary 
diagnosis continuing to rise. There is a positive relationship 
between the prevalence of heart failure and age. However, 
mortality from heart failure is on the decline due to medical 
advancements, pharmacotherapy and nonpharmacological 
interventions. One of these nonpharmacological interventions 
is physical training or exercise. Physical training or exercise 
is becoming widely accepted by the medical community as 
a viable option in the medical management of stable heart 
failure patients. Both aerobic and resistance type exercise 
have been shown to be efﬁcacious in stable heart failure 
patients. Evidence now exists not only supporting exercise 
to improve or maintain physical function in heart failure 
patients, but also quality of life. Many studies have shown 
that utilizing exercise in this population improves mood and 
overall self-reported well being. While the myocardial beneﬁts 
from exercise may be minimal in heart failure patients, the 
peripheral beneﬁts leading to improved physical function and 
preservation of independence are indispensible. Based on 
the research that has been conducted in the area of exercise 
and heart failure to this point, clinicians working with this 
population have the data necessary to prescribe evidence-
based exercise prescriptions that can be utilized as part of 
a comprehensive medical management approach. Currently, 
several medical position statements endorse exercise as a 
safe and effective modality in heart failure patients.
(Key words: CHF, heart failure. physical activity, quality of life, 
aerobic, muscular strength)
INTRODUCTION
Heart failure (HF) has become a mounting health care concern and 
economic burden in North and South America. The cost for treatment of 
HF is escalating due to the increased number of people living with this 
problem. Costs related to HF are predicted to reach $44.6 billion in the 
United States (U.S.) by 2015 (1). HF is deﬁned by the presentation of 
multifaceted clinical symptoms that are due to a functional or structural 
cardiac disorder that impairs the ability of the heart to ﬁll or eject 
blood. The subjective complaints of HF are dyspnea and fatigue, which 
in turn, attenuate exercise tolerance and may cause ﬂuid retention. 
This ultimately leads to pulmonary or peripheral edema (2). HF may 
be caused by impaired left ventricular function due to coronary artery 
disease, dilated cardiomyopathy, hypertension, structural congenital 
heart disease, myocarditis, valvular heart disease, rheumatic heart 
disease, myocardial infarction, Chagas disease, abnormal heart rhythms 
or idiopathic cardiomyopathy.
These numbers are augmented due to an aging population and improved 
survival following critical cardiac events. Due to survival of early cardiac 
events, the incidence of HF is increasing, but mortality related to HF is 
decreasing slowly due to improved intervention strategies. In addition 
to advanced medical technology and pharmacotherapy, exercise is 
becoming an important part of managing HF patients with viable left 
ventricular function.
Many exercise studies have demonstrated improvements in functional 
capacity (aerobic ﬁtness) in HF patients similar to those seen in healthy 
populations.  Exercise training studies in HF patients have demonstrated 
improvements of 18 to 25% in peak oxygen consumption and 18 to 34% 
in peak exercise duration with symptoms, functional class and quality of 
life measures also improving (3). These data and other resulted in the 
American College of Cardiology and the American Heart Association to 
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recognize exercise training in HF patients as a beneﬁcial intervention 
(4). Exercise training is being used to treat people with HF because it 
has been shown to impart physiological and psychological beneﬁts (5-7). 
INCIDENCE AND PREVALENCE
Many countries disclose escalating numbers of people with heart 
disease and HF.  In the U.S., it is estimated that more than 550,000 new 
HF diagnoses are made each year and more than ﬁve million people 
are currently living with HF (8). In the U.S., between 1990 and 1999, 
hospitalizations with HF as a primary diagnosis have gone from 810,000 
to more than one million. Furthermore, these numbers reached 3.6 million 
when HF was a primary or secondary diagnosis (9). HF affects 2.4% of 
the adult population and the incidence is increasing with age to over 7% 
in people above 75 years of age. The lifetime risk of developing HF at age 
40 is 20% in females and 21% in males. A decrease in mortality with 
HF is leading to an increase in prevalence. Age-adjusted increase in HF 
noted in one community based study (1996-2000) reveals 29 per 10,000 
in women and 38 per 10,000 for men (8). HF mortality has decreased 
from 57% between 1979 and 1984 to 48% between 1996 and 2000 
(10). The largest inﬂuencing factor for HF prevalence and incidence is the 
growing elderly population. The number of persons diagnosed with HF is 
predicted to double from 2000-2030 (9).
Trends in countries such as those in South America (SA) reveal the 
number of people with HF is steadily reaching the number in North 
America and the Western World. Coronary artery disease in the presence 
of hypertension and diabetes mellitus is the most common cause of HF 
in SA (11). In 2002, 1,524 hospital admissions in Brazil were due to HF, 
which reﬂects approximately 3% of all admissions (12). In 2002, 6.9% 
of all hospital mortality in SA was due to HF. Furthermore, the prevalence 
of HF in SA is estimated to be approximately 4% in those over 65. In 
2003, the World Heart Failure Society reported approximately 30,000 
deaths due to HF with the majority of the mortality occurring in those 
>75 years of age (13). 
HF is the leading cause of hospitalizations in SA due to coronary artery 
disease, valvular heart disease, idiopathic dilated cardiomyopathy and 
chagastic symptoms. HF is responsible for 6.3% of all deaths in SA. Chagas 
heart disease is a cause of heart failure in many Latin American countries 
and has become a serious health and economic crisis and mortality from 
Chagas disease related HF is high. Chagas disease is usually acquired 
during childhood as the host is infected with Trypanosoma cruzi. This 
parasitic disease is transmitted to humans through the feces of infected 
insects found in endemic areas such as poor rural housing (14). Focusing 
on prevention and early treatment of Chagas disease will likely reduce 
the incidence of HF in SA countries (15).     
AEROBIC EXERCISE TRAINING IN HEART FAILURE
In addition to traditional and advanced medical management, physical 
activity and exercise are well-recognized therapies for HF and have 
been shown to improve cardiac function, quality of life and reduce 
symptoms related to HF. In people with normal heart function, aerobic 
exercise training results in improved cardiovascular function and oxygen 
consumption and a lower resting heart rate as well as an improved rate-
pressure product. The improvement in oxygen consumption results from 
increased cardiac output and oxygen extraction by working muscles. The 
increased cardiac output results from an increase in ventricular ﬁlling 
and higher stroke volume. There is an increase in the size of the coronary 
vascular bed and a greater capacity for the coronary arteries to dilate. 
Blood volume increases and the blood is less viscous which decreases 
resistance to ﬂow and improves the delivery of oxygen . 
Aerobic exercise training for HF patients is generally prescribed at 70 to 
80% of the heart rate achieved on the exercise test. This is considered a 
moderate to high intensity range. Some patients cannot exercise at this 
level and will beneﬁt from a lower intensity (16,17). As with people with 
normal left ventricular function, patients with HF are advised to exercise 
30 minutes or more ﬁve or more days weekly.  This can be continuous or 
divided into shorter intervals. One study compared the effect of aerobic 
interval training (AIT) with moderate continuous exercise of 60 to 70% 
peak heart rate in HF patients (18).  The AIT group performed three to 
four minute intervals of high intensity exercise of 90 to 95% peak heart 
rate. The AIT group showed higher oxygen consumption, more reverse 
left ventricular remodeling or increase in ejection fraction, and decreased 
left ventricular volume. Endothelial and mitochondrial function were also 
more favorably impacted with AIT. These changes are important due to 
both endothelial and mitochondrial function diminishing with age.
Muscle wasting also occurs in normal aging as well in HF patients. This 
contributes to exercise intolerance and morbidity and mortality. A recent 
study demonstrated exercise turns off the muscle wasting pathways and 
turns on the pathways involved in muscle growth in both HF patient 
groups of those less than 55 years of age and those greater than 65 
years of age.  Before and after the exercise intervention vastus lateralis 
muscle biopsies were obtained. Speciﬁcally, the exercise program of four 
weeks at 70% of peak oxygen consumption reduced levels of muscle 
ring ﬁnger 1 (MuRF-1) by 32.8% in patients younger than 55 (P=0.02) 
and by 37% (P<0.05) in those 65 and over.  The authors conclude, 
MuRF-1, a component of the ubiquitin-proteasome system involved in 
muscle proteolysis, is increased in the skeletal muscle of patients with 
HF.  Exercise training results in reduced MuRF-1 levels, suggesting that 
it blocks ubiquitin-proteasome system activation and does so in both 
younger and older HF patients.  There was also a marked improvement in 
oxygen consumption following training in both groups (19).         
The recent HF-ACTION trial (20) enrolled 2331 patients at 82 study 
sites in the US, Canada, and France. This was a multi-center, randomized 
controlled trial designed to measure the effects of exercise on clinical 
outcomes in medically optimized and stable patients with systolic HF (left 
ventricular ejection fraction less than 35%). Patients either received usual 
care or usual care plus an exercise-training program.  The training was 
initially supervised then transitioned to a home-based exercise program. 
The mean left ventricular ejection fraction (LVEF) was 25%, the average 
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age of the patients was 59, and one-third were women.  The exercise 
program gradually progressed, with a goal of three 30-minute exercise 
sessions three times a week.  The exercise group worked at a moderate 
intensity, which was 60 to 70% of their heart rate reserve.  Following 
18 sessions they transitioned to the home-based exercise program, with 
the goal being 40 minutes four days a week and the protocols being a 
stationery bike or treadmill. Patients were followed for an average of 2.5 
years.  Investigators found that exercise resulted in an 11% reduction 
in risk of hospitalization or mortality (p= .03). When examining a 
secondary end point of this study, the exercise group had a 15% lower 
risk of mortality from cardiovascular disease and hospitalization due to 
complications of HF (p=.03).
The loss of physical function in heart failure is well documented and 
contributes to difﬁculties in performing both leisure time and activities 
of daily living (ADLs) .  In part due to an attenuated tolerance to physical 
exertion (21), HF patients have difﬁculty performing normal ADLs, which 
generally employ more upper than lower extremity activity.  The difﬁculty 
in performing ADLs is a major factor reducing quality of life (QOL) in 
those with HF. In individuals with HF, exercise training can increase 
physical endurance (22) and has been shown in some but not all studies 
to improve health-related QOL (17,23-27). The reasons for incongruity 
between studies may be related to how subjects train (upper extremity 
vs. lower extremity protocols) and intensities of the exercise programs.  
UPPER EXTREMITY EXERCISE TRAINING
Research has shown exercise training in subjects with left ventricular 
dysfunction to be safe and efﬁcacious. The functional beneﬁts relate to 
skeletal muscle improvement as well as changes in cardiac dynamics 
(5,6). However, the majority of previous research studies utilized 
exercise programs of short duration (three to 12 weeks) and involved 
predominantly lower extremity exercise training.  There are fewer studies 
supporting improved left ventricular function when the exercise-training 
program is of longer duration or greater intensity. Additionally, lower 
extremity exercises have been more commonly prescribed compared with 
upper extremity exercises in many studies.  
Based on this previous research, a pilot study was done utilizing an upper 
body ergometer (UBE) in HF patients (28). The investigators hypothesized 
that UBE training should be beneﬁcial in reducing exercise intolerance 
during activities that require sustained arm work. Since most ADLs 
involve upper extremities, training on an UBE should be beneﬁcial in this 
group. Subjects were more than three months post myocardial infarction, 
were stable and on pharmacotherapy. Ten subjects with mean LVEF of 
30 +/- 6 (New York Heart Association (NYHA) Class II- III) were recruited 
(Table 1) (29). 
Subjects were administered the Minnesota Living with Heart Failure 
Questionnaire, the Medical Outcomes Study Short Form-36 and had 
symptom-limited UBE cardiopulmonary testing with echocardiography. 
Following UBE testing subjects were enrolled in cardiac rehabilitation 
for 12 to 15 weeks. Upper extremity training was performed for 40 
minutes three times a week, using a UBE, the upper extremity handles 
of a NuStep® device and an Airdyne® stationery cycle. Target heart rate 
was 75 -85% of peak heart rate on baseline exercise testing.  Follow-up 
testing was conducted at the end of the exercise-training period.
Six men and one woman, with a mean age of 68 +/- 4 years completed 
the study. Three subjects dropped out because of health problems 
unrelated to the exercise training protocol or worsening of HF. UBE 
training increased arm exercise test duration by approximated 22% 
(p=.008), Cohen’s d=1.5)). Echocardiogram results showed resting 
LVEF was not changed. Maximal exercise LVEF mean values were not 
statistically different (p=.16) but Cohen’s d=0.53 indicated a moderate 
improved change.
The mean Minnesota Living with Heart Failure Questionnaire total score 
was improved following the intervention (p=.02, Cohen’s d= 1.1), and 
six out of seven participants exhibited a clinically signiﬁcant difference 
of greater than ﬁve points.  The Medical Outcomes Study Short Form-
36 total score showed ﬁve subjects had a change in scores ranging 
from three to 13 points on the 100-point scale (p=.05, Cohen’s d=.5). 
Signiﬁcant improvements were present for role limitation due to improved 
physical functioning (P=.04, Cohen’s d = 1.0). The improvements 
TABLA 1. NEW YORK HEART ASSOCIATION 
FUNCTIONAL CLASSIFICATION OF HEART FAILURE
I
II
III
IV
Recognized cardiovascular disease without 
limitations to physical activity. Ordinary physical 
activity does not result in undue fatigue, 
dyspnea, palpitations, or angina.
Recognized cardiovascular disease with slight 
limitations to physical activity. Patients are 
comfortable at rest yet may experience undue 
fatigue, dyspnea, palpitations, or angina during 
ordinary physical activity.
Recognized cardiovascular disease with marked 
limitations to physical activity. Patients are 
comfortable at rest yet experience undue 
fatigue, dyspnea, palpitations, or angina 
less-than-ordinary physical activity.
Recognized cardiovascular disease with 
symptoms of cardiac insufﬁciency at rest. Any 
physical activity results in increased discomfort.
NYHA CLASS PATIENT SYMPTOMS
Adapted from The Criteria Committee of the New York Heart Association (29)
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in overall QOL and exercise duration without a deleterious change in 
LVEF are encouraging for the use of upper extremity exercise training in 
HF.  Continued research is warranted for speciﬁc duration and mode of 
exercise training in HF patients.
RESISTANCE EXERCISE
The hallmark symptoms of HF are dyspnea, fatigue and exercise 
intolerance. There is a growing body of evidence supporting the role 
of skeletal muscle dysfunction (reductions in skeletal muscle mass, 
strength, and endurance) contributing to the increased fatigue and 
exercise intolerance exhibited in HF patients. Additionally, the degree of 
skeletal muscle dysfunction in HF negatively impacts functional mobility, 
which further diminishes the ability to complete ADLs, reported QOL, and 
disease prognosis.
Skeletal muscle mass and strength are signiﬁcantly correlated with 
exercise capacity in HF and can independently predict survival in patients 
with severe HF (30-34).  Harrington et al. (32) categorized 100 HF patients 
by severity of their exercise limitations (as measured with peak VO2 in 
ml/kg/min); mild 24.7 ml/kg/min, moderate 17.4 ml/kg/min, and severe 
12.2 ml/kg/min. Muscle strength, quadriceps cross-sectional area, and 
total thigh cross-sectional area were attenuated with increasing severity 
of exercise intolerance. Izawa et al. (33) found signiﬁcant decreases in 
VO2peak in HF patients as NYHA functional class progressed from class 
I to class III (23.4, 19.6, and 14.7 ml/kg/min respectively) (Table 1). 
Importantly, both upper body and lower body muscular strength were 
found to predict VO2peak in these patients. Hulsmann et al. (31) reported 
that knee ﬂexor strength was superior to VO2peak and workload as a 
predictor of mortality in severe HF patients (LVEF 21%), highlighting the 
importance of muscular strengthening activities (MSA).
QOL measures in HF patients decrease signiﬁcantly by NYHA functional 
class and are signiﬁcantly reduced when compared to a healthy reference 
group (35). Changes in QOL in HF patients can be better explained by 
exercise capacity (six-minute walk test and VO2peak) than LVEF (35). 
Additionally, ADLs and QOL can independently predict mortality and HF-
related hospitalizations (36). As mentioned above, engaging in MSA, plays 
a primary role in optimizing exercise capacity in HF and therefore should 
positively impact ADLs, QOL, mortality, and HF-related hospitalizations.
Resistance training (RT) has traditionally been the exercise modality of 
choice to slow the loss of both skeletal muscle mass and strength and 
facilitate muscle hypertrophy, muscular strength, and anaerobic ﬁtness in 
both clinical and healthy populations. Therefore, RT is gaining acceptance 
as an adjunct therapy to aerobic exercise in stable HF patients that 
have been prescribed exercise therapy. Unfortunately, early reports of a 
considerable pressure load being placed on the heart of young healthy 
subjects completing maximal or near maximal static or dynamic RT 
discouraged many clinicians from considering this intervention in the 
rehabilitation programs of HF patients (37). The initial concerns were 
that RT would further deteriorate left ventricular structure and function. 
Further investigation identiﬁed several factors in RT exercise prescription 
which inﬂuence the severity of the pressure load (38):
1) The magnitude of relative load to a one repetition maximum (1-RM). 
The pressure load increases as the load increases toward the maximal 
weight an individual can lift for only one repetition. Example: If the 1-RM 
of a patient is 100 lbs, the pressure load will be greater when he lifts 100 
lbs one time than when he lifts a submaximal weight (60 lbs) one time.
2) The number of repetitions relative to a multiple repetition maximum. 
The pressure load increases as the lifter approaches volitional fatigue 
with multiple repetitions. Example:  If a patient can lift 60 lbs 20 
consecutive times before fatigue, the pressure load will be greater during 
the 20th repetition than during the 15th repetition.
3) The volume of contracting muscle mass. Bilateral limb RT exercises 
create a greater pressure load than unilateral limb RT exercises. Two 
muscles contracting at the same time create a greater pressure load than 
one muscle contracting at the same relative intensity.
4) Duration of the muscle contraction relative to the rest between 
repetitions and sets. When rest between sets is short, subsequent sets of 
the same relative workload will increase the pressure load. Therefore, rest 
between sets is recommended to have a minimum of 1:2 work to rest 
ratio. Example: If a set of 10-repetitions takes one minute to complete, 
the rest period before a subsequent RT exercise is performed must be at 
least two-minutes. 
More recently, clinicians with RT program design expertise have 
developed low or moderate resistance exercise protocols, which minimize 
the pressure load and have been well tolerated by patients diagnosed 
with HF (38-40). Clearly the implementation of exercise programs in 
the treatment and rehabilitation of HF patients is an evolving practice. 
Indeed, in the past 10 years professional guidelines recommended by the 
American College of Sports Medicine (41), American Heart Association 
(42), Heart Failure Association and the European Society of Cardiology 
(43), and Exercise and Sports Science Australia (44) have endorsed the 
implementation of RT exercises in the treatment and rehabilitation of HF 
patients. Speciﬁc position statements have been published detailing RT 
exercise prescriptions in HF (43,44).
RESISTANCE TRAINING INTERVENTIONS IN HF
The most important recent research ﬁndings are that properly designed 
RT programs in HF patients do not have a negative impact on LV function 
or structure. Furthermore, RT is well tolerated by patients with HF 
(43-45). Following an eight-week structured RT protocol involving 10 
NYHA class II or III (Table 1) male patients performing two sets of 12 RT 
exercises at 60% 1-RM three days per week, signiﬁcant improvements in 
LVEF (pre 32% vs. post 37%) and stroke volume (pre 46 ml/beat vs. 53 
ml/beat) were observed (46). A review by Smart and Marwick45 of 81 
exercise studies in patients with HF reported no exercise related deaths 
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in over 60,000 patient-hours of exercise (30% of these studies included 
RT either separately or in combination with aerobic exercise).
Consistent improvements in muscular strength and endurance, often 
exceeding 20 to 30%, have been reported with RT interventions in 
HF (5,6). RT has consistently attenuated age or disease related muscle 
loss in HF patients and evidence exists that shows increases in lean 
mass. Feiereisen et al. (47) randomized 45 male and female NYHA 
class II and III (Table 1) HF patients with LVEF <35% into either a RT 
group that performed four sets of 10 exercises at 60 to 70% 1-RM, 
an aerobic training group that performed bicycle and treadmill exercise 
at 60 to 75% VO2peak, or a combination of RT and aerobic training. 
All subjects performed 40 exercise sessions lasting 40 minutes each. 
Fifteen HF patients who were unable to attend exercise sessions due to 
geographic constraints were used as controls. Signiﬁcant strength gains 
were only recorded among the RT and combination groups. Interestingly, 
quadriceps muscle mass (measured by CT scan), VO2peak, LVEF, left 
ventricular end-systolic volume, left ventricular end-diastolic volume, and 
QOL signiﬁcantly improved in all three training groups. No change in 
these parameters was observed in the controls.
RT interventions in HF have resulted in signiﬁcant improvements 
in patient QOL. Edelmann et al. (48) studied 64 male and female HF 
patients NYHA functional class II and III (Table 1) with a mean age of 65. 
Forty-four patients were randomized in to either a 32-session exercise-
training group that included both RT (one set if 15 repetitions at 60-
65% 1-RM of six different upper and lower body exercises twice a week) 
and aerobic training (cycling two to three days a week at 50 to 70% 
VO2peak) or a usual care control group. Signiﬁcant improvements were 
reported using both the Medical Outcomes Study Short Form-36 and the 
Minnesota Living with Heart Failure Questionnaire. No improvement in 
QOL was found in the control group. 
While the primary role of aerobic exercise in HF cannot be discounted, 
the inclusion of dynamic resistance exercise as a secondary and 
complimentary exercise modality is now broadly recognized in HF 
treatment guidelines. Although, speciﬁc precautions should be taken 
when adopting RT exercise in HF:
1) Patients must be clinically stable and have demonstrated aerobic 
exercise tolerance before beginning RT.
2) RT intensity should be individualized.
3) Start slow and progress slowly.
4) Monitor ECG, BP, perceived exertion, and body weight.
5) Be cognizant of possible indications that the severity of HF may have 
changed.
6) RT is usually contraindicated for NYHA Class IV HF patients (Table 1).
Generally initial RT loads should be light, with patients completing 6 
to 15 repetitions without strain (10 to 13 on the 6 to 20 Borg scale of 
perceived exercise) of exercises that address both upper and lower body 
muscles one to two days a week. Exercise pace should be slow, allowing 
at least twice the time for rest/recovery phases as compared to work/
contraction phases. Beginning with unilateral exercises can increase RT 
exercise tolerance. Load and frequency can be slowly progressed over 
time to an exertion level of 11 to 15 (on the 6 to 20 Borg scale) and 
two to three days per week. For more detailed exercise prescription 
criteria, please refer to the publication by Braith et al. (38). An example 
integrating the 15 grade and 10 grade Borg Ratings of Perceived Exertion 
can be found in Table 2 (49).
TABLA 2. BORG 15 GRADE AND 10 GRADE RATING 
OF PERCEIVED EXERTION (RPE) SCALES 
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
1
2
3
4
5
6
7
8-9
10
Very, very, light
Very light
 Fairly light
Moderate
Somewhat hard
Hard
Very Hard
Very, very, hard
15 Grade 
Scale
Verbal expression 
of perceived exertion
10 Grade Scaleof 
perceived exertion
Adapted from Borg (49)
Finally, clinicians also need to be cognizant of rate-pressure product (RPP) 
(also known as double-product). This unitless indicator of myocardial 
oxygen demand is the product of systolic blood pressure and heart 
rate. RPP is typically utilized in a clinical or rehabilitative setting when 
prescribing exercise. Any combination of systolic blood pressure and 
heart rate resulting in an RPP that brings on patient symptoms should 
be avoided. For example, our case patient reported angina at an RPP of 
24000 (160 mmHg x 150 bpm). This same patient will also experience 
angina when his systolic blood pressure and heart rate responses are 
136 mmHg and 177 bpm respectively. This is important because various 
modes of exercise produce different hemodynamic responses. RPP is also 
a good indicator of exercise training progress. A lower RPP at a similar 
previous workload indicates improved functional capacity or ﬁtness. A 
greater RPP could indicate declining functional status or when dealing 
with ischemic heart disease progression of disease. RPP is an excellent 
non-invasive clinical tool.
THE AUTHORS HAVE PROVIDED THE FOLLOWING CLINICAL 
CASE REPORT 
RT in a 59-year-old male from Santiago, Chile. He previously worked as 
a butcher in a local grocery store.  He had a myocardial infarction in 
May, 2012 resulting in HF with a left ventricular ejection fraction of 32% 
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(Class II NYHA).  Now, in August, he is stable with some fatigue and 
dyspnea during ADLs. He reports taking his cardiovascular medications 
on a regular basis.  He is doing some walking in his neighborhood, but 
wants to increase his physical activity level and hopefully return to work. 
His physician agrees, but wants an exercise test to more accurately 
prescribe his exercise.  The modiﬁed Bruce protocol treadmill test with 
oxygen consumption was done and the following data were obtained:
Time on treadmill - 11 minutes
Resting heart-rate (RHR) = 68 beats per minute (bpm)
Heart rate - 68 to 150 bpm
Exercising blood pressure response - 130/80 to 160/90 mmHg
RPE - 16
VO2peak - 18 ml/kg/min 
METs – 5.1 (3.5 ml/kg/min = 1 MET)
RPP – 24000 (at peak exercise)
End points were shortness of breath (SOB) with no angina. ECG showed 
slight non-signiﬁcant (non-diagnostic) ST depression.
Based on these results, his physician and healthcare team prescribed the 
following aerobic exercise program.  The exercise was to be performed in 
cardiac rehabilitation three days weekly with additional walking at home 
two to three days weekly.
CARDIAC REHABILITATION EXERCISE PROGRAM
AEROBIC EXERCISE
Exercise intensity can be prescribed based on HR (55 to 80% heart-rate 
reserve (HRR), RPE, and VO2 or MET level (40 to 75% VO2peak).
s Calculation of HRR = Peak HR – RHR = 150-68 = 82 bpm
Determining exercise intensity based on HRR (HRR x training level + RHR)
s Calculation of “low end” of exercise intensity using HRR: 
(82 x 55% + 68) = 113 bpm
s Calculation of “high end” of exercise intensity using HRR: 
(82 x .80 + 68) = 134 bpm
s Prescribed exercise intensity based on 
HRR = Obtain and maintain exercise HR between 113 to134 bpm.
Alternatively, RPE, or MET level can be used for prescribing exercise 
intensity in patients where HRR is either inappropriate or inadequate 
(e.g., beta-blockers or atrial ﬁbrillation)
RPE of 11 to 14 (fairly light to somewhat hard)
s Calculation of Exercise intensity based on VO2peak or MET level: 
40 to 75% VO2 peak =  7 to 13 ml/kg/min or approximately 2 to 4 METs.
Prescribed aerobic exercise intensity: 113 to 134 bpm, RPE 11to 14, or 2 
to 4 METS. Workloads will be adjusted periodically to maintain prescribed 
intensity (as the patient becomes more conditioned, previous workloads 
will result in lower exercise HR and perceived exertion).
WARM UP - Five minutes slow walking in facility
Exercise Duration - Initially 10 to 20 minutes progressing gradually as 
patient demonstrates tolerance to 40 to 60 minutes.
Mode - Treadmill walking, stationary cycling, elliptical, UBE, rowing 
ergometer, etc. Patient is encouraged to divide his aerobic exercise time 
between multiple exercise modes. He is also advised to use modes that 
incorporate arm exercise to better prepare him for return to work.
Cool Down - Five minutes slow walking in facility Aerobic exercise may 
be done continuously or with short breaks depending upon symptoms 
and staying within target ranges.
Home Walk Program
Week 1 - 2 - Walk ½  mile in 10 minutes twice daily*
Week 3 - 4 - Walk 1 mile in 20 minutes twice daily*
Week 5 - 6 - Walk 1.5 miles in 30 minutes twice daily*
Week 7 - 8 - Walk 2 miles in 40 minutes*
Week 9 - on - Continue walking 30 – 60 minutes two to three days per 
week at a 20-minute per mile pace or faster if tolerated (can perform 
intervals or continuous bouts of walking)* 
*If dizziness, SOB, angina, or irregular heart beat occur, stop the exercise 
and report symptoms to your health care team. Walking should be done 
on level ground if possible.
RESISTANCE EXERCISE
Once aerobic exercise tolerance has been demonstrated, resistance 
exercise can be initiated in three progressive steps. Resistance exercise 
should be performed in addition to aerobic exercise.
1) Instruction period (one to two weeks): Patient is shown two to 
three dynamic RT exercises segmented for upper or lower body muscle 
groups (four to six exercises total) and is instructed to complete ﬁve to 
10 repetitions. Exercise intensity should be light with an RPE of about 10 
on the 15-grade scale (<30% 1RM) (Table 2). These exercises should be 
performed two to three days per week. The focus should be on enhancing 
coordination of movement and checking for any orthopedic limitations 
throughout the range of motion for RT exercises. 
2) Resistance/muscle endurance period (two to four weeks): 
Load is gradually increased from light (RPE of 10) to moderate (RPE 
of 12) and then to somewhat hard (RPE of 13) as tolerated (Table 2). 
Repetitions can range from eight to 15 per exercise. Repetitions should 
be performed in a controlled fashion (one to three seconds concentric, 
one to three seconds eccentric). Allow for at least a 1:2 work to rest ratio 
(if the patient completes 10 repetitions of dynamic RT in one minute 
allow at least two minutes for recovery before moving on to the next 
exercise). These exercises should be performed two to three days per 
week. At no time should the patient be straining to complete a repetition 
at this workload. 
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